Related references
Note: Only part of the references are listed.Histologic Healing Is More Strongly Associated with Clinical Outcomes in Ileal Crohn's Disease than Endoscopic Healing
Britt Christensen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Intestinal Epithelial Cells Express Immunomodulatory ISG15 During Active Ulcerative Colitis and Crohn's Disease
Ann Elisabet Ostvik et al.
JOURNAL OF CROHNS & COLITIS (2020)
Evolution of treatment targets in Crohn's disease
Jonathan R. White et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2019)
Correlation between endoscopic and histological validated scoring indices in Crohn's disease
Wenbin Gong et al.
DIGESTIVE AND LIVER DISEASE (2019)
Correlation and concordance measures between clinical, endoscopic and histological scores activity in Crohn's disease under treatment
Joao Batista Tajra et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2019)
Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease
Mark Lowenberg et al.
GASTROENTEROLOGY (2019)
Effects of Ustekinumab on Histologic Disease Activity in Patients With Crohn's Disease
Katherine Li et al.
GASTROENTEROLOGY (2019)
Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease
Silvio Danese et al.
GASTROENTEROLOGY (2019)
STAT3 Genotypic Variant rs744166 and Increased Tyrosine Phosphorylation of STAT3 in IL-23 Responsive Innate Lymphoid Cells during Pathogenesis of Crohn's Disease
Ying Tang et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Can advanced endoscopic techniques for assessment of mucosal inflammation and healing approximate histology in inflammatory bowel disease?
Olga Maria Nardone et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2019)
Molecular classification of Crohn's disease reveals two clinically relevant subtypes
Matthew Weiser et al.
GUT (2018)
ACG Clinical Guideline: Management of Crohn's Disease in Adults
Gary R. Lichtenstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
P633 Concordance between endoscopy and histology scores at baseline and following induction therapy with the JAK1 inhibitor filgotinib in active Crohn’s disease: Results from FITZROY study
W Reinisch et al.
Journal of Crohns & Colitis (2018)
JAK-1 Inhibition Suppresses Interferon-Induced BAFF Production in Human Salivary Gland Potential Therapeutic Strategy for Primary Sjogren's Syndrome
Jaeseon Lee et al.
ARTHRITIS & RHEUMATOLOGY (2018)
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management
Fernando Gomollon et al.
JOURNAL OF CROHNS & COLITIS (2017)
Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing in Mice With Colitis and Is Increased in Mucosa of Patients With Inflammatory Bowel Disease
Mircea T. Chiriac et al.
GASTROENTEROLOGY (2017)
Impact of Histological and Endoscopic Remissions on Clinical Recurrence and Recurrence-free Time in Ulcerative Colitis
Ana Ponte et al.
INFLAMMATORY BOWEL DISEASES (2017)
Clinical Implications of Histologic Abnormalities in Ileocolonic Biopsies of Patients With Crohn's Disease in Remission
Gregory T. Brennan et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2017)
Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial
Severine Vermeire et al.
LANCET (2017)
Acute histological inflammatory activity is associated with clinical relapse in patients with ulcerative colitis in clinical and endoscopic remission
Margalida Calafat et al.
DIGESTIVE AND LIVER DISEASE (2017)
Mechanisms and consequences of Jak-STAT signaling in the immune system
Alejandro V. Villarino et al.
NATURE IMMUNOLOGY (2017)
Prognostic factors for long-term infliximab treatment in Crohn's disease patients: a 20-year single centre experience
T. Billiet et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Histological Disease Activity as a Predictor of Clinical Relapse Among Patients With Ulcerative Colitis: Systematic Review and Meta-Analysis
Sunhee Park et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
L. Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection
Florence Namour et al.
CLINICAL PHARMACOKINETICS (2015)
Preclinical Characterization of GLPG0634, a Selective Inhibitor of JAK1, for the Treatment of Inflammatory Diseases
Luc Van Rompaey et al.
JOURNAL OF IMMUNOLOGY (2013)
Share Paper
